Related Experiment Video
Updated: Jun 6, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Cardiac complications from cancer therapy
1Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical Center, USA. blaes004@umn.edu
Abstract:
In 2005, more than 10 million people in the United States were cancer survivors, and that number is expected to grow as therapies for cancer improve and the population ages. Although survival is something to be celebrated, it can be accompanied by a number of health problems secondary to the initial disease and its treatment. Cardiovascular problems are emerging as a particular concern among the survivor population. This article reviews what is known about the kinds and rates of cardiovascular complications common to cancer survivors, the treatments that caused them, and the risk factors for them. It also presents guidance for primary care providers caring for survivors who may be at risk of cardiovascular complications.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiac Catheterization II: Right Heart Catheterization
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
